Long-term Cancer-specific Outcomes of TaG1 Urothelial Carcinoma of the Bladder-Reference-Cited by-同舟云学术

Long-term Cancer-specific Outcomes of TaG1 Urothelial Carcinoma of the Bladder

Published:2014-01 Issue:1 Volume:65 Page:201-209
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Rieken Malte,Xylinas Evanguelos,Kluth Luis,Crivelli Joseph J.,Chrystal James,Faison Talia,Lotan Yair,Karakiewicz Pierre I.,Holmäng Sten,Babjuk Marek,Fajkovic Harun,Seitz Christian,Klatte Tobias,Pycha Armin,Bachmann Alexander,Scherr Douglas S.,Shariat Shahrokh F.

Publisher

Elsevier BV

Subject

Urology

Reference23 articles.

1. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines;Stenzl;Eur Urol,2011

2. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

3. Babjuk M, Burger M, Zigeuner R, et al. Guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). Uroweb 2013. http://www.uroweb.org/gls/pdf05_TaT1_Bladder_Cancer_LR.pdf.

4. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

5. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update;Babjuk;Eur Urol,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-Escalation of Therapy for Low-Grade Papillary Bladder Tumors With Preserved Long-Term Oncologic Outcomes;Urology Practice;2024-09

2. Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over Time;Urology;2024-07

3. Long-term Recurrence Rates of Low-risk Non–muscle-invasive Bladder Cancer—How Long Is Cystoscopic Surveillance Necessary?;European Urology Focus;2023-07

4. Intermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group;European Urology Oncology;2022-10

5. Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?;Current Opinion in Urology;2022-07-22